Literature DB >> 20887319

Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'.

Lucas McCormack1, Emilio Quiñonez, María Martha Ríos, Pablo Capitanich, Nicolás Goldaracena, Javier Kerman Cabo, Margarita Anders, Javier Osatnik, Pablo Comignani, Norberto Mezzadri, Ricardo Cesar Mastai.   

Abstract

BACKGROUND: There is a worldwide need to expand the donor liver pool. We report a consecutive series of elective candidates for liver transplantation (LT) who received 'livers that nobody wants' (LNWs) in Argentina.
METHODS: Between 2006 and 2009, outcomes for patients who received LNWs were analysed and compared with outcomes for a control group. To be defined as an LNW, an organ is required to fulfil two criteria. Firstly, each liver must be officially offered and refused more than 30 times; secondly, the liver must be refused by at least 50% of the LT programmes in our country before our programme can accept it. Principal endpoints were primary graft non-function (PNF), mortality, and graft and patient survival.
RESULTS: We transplanted 26 LNWs that had been discarded by a median of 12 centres. A total of 2666 reasons for refusal had been registered. These included poor donor status (n= 1980), followed by LT centre (n= 398) or recipient (n= 288) conditions. Incidences of PNF (3.8% vs. 4.0%), in-hospital mortality (3.8% vs. 8.0%), 1-year patient (84% vs. 84%) and graft (84% vs. 80%) survival were equal in the LNW and control groups.
CONCLUSIONS: Transplantable livers are unnecessarily discarded by the transplant community. External and internal supervision of the activity of each LT programme is urgently needed to guarantee high standards of excellence.
© 2010 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2010        PMID: 20887319      PMCID: PMC2997657          DOI: 10.1111/j.1477-2574.2010.00193.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  27 in total

1.  MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game.

Authors:  Didier Samuel
Journal:  J Hepatol       Date:  2009-01-09       Impact factor: 25.083

Review 2.  Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation.

Authors:  S M Strasberg; T K Howard; E P Molmenti; M Hertl
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

3.  Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with "livers that nobody wants".

Authors:  Georgios C Sotiropoulos; Andreas Paul; Ernesto Molmenti; Hauke Lang; Andrea Frilling; Bogdan P Napieralski; Silvio Nadalin; Jürgen Treckmann; Eirini I Brokalaki; Till Gerling; Christoph E Broelsch; Massimo Malagó
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

4.  A proposal for scoring marginal liver grafts.

Authors:  J Briceño; G Solórzano; C Pera
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

Review 5.  Patient selection in an era of donor liver shortage: current US policy.

Authors:  Russell H Wiesner
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-01

6.  Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor.

Authors:  Philipp Dutkowski; Katarzyna Furrer; Yinghua Tian; Rolf Graf; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

7.  Policies in Europe on "marginal quality" donor livers.

Authors:  D F Mirza; B K Gunson; R F Da Silva; A D Mayer; J A Buckels; P McMaster
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

Review 8.  Risk of extended criteria donors in hepatitis C virus-positive recipients.

Authors:  Marina Berenguer
Journal:  Liver Transpl       Date:  2008-10       Impact factor: 5.799

9.  Effect of extended cold ischaemia with UW solution on graft function after liver transplantation.

Authors:  R Adam; H Bismuth; T Diamond; B Ducot; M Morino; I Astarcioglu; M Johann; D Azoulay; L Chiche; Y M Bao
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

10.  Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.

Authors:  Michael L Volk; Anna S F Lok; Shawn J Pelletier; Peter A Ubel; Rodney A Hayward
Journal:  Gastroenterology       Date:  2008-11       Impact factor: 22.682

View more
  5 in total

Review 1.  Normothermic Machine Perfusion-Improving the Supply of Transplantable Livers for High-Risk Recipients.

Authors:  Angus Hann; Anisa Nutu; George Clarke; Ishaan Patel; Dimitri Sneiders; Ye H Oo; Hermien Hartog; M Thamara P R Perera
Journal:  Transpl Int       Date:  2022-05-31       Impact factor: 3.842

2.  Deceased Brain Dead Donor Liver Transplantation and Utilization in the United States: Nighttime and Weekend Effects.

Authors:  Dustin J Carpenter; Mariana C Chiles; Elizabeth C Verna; Karim J Halazun; Jean C Emond; Lloyd E Ratner; Sumit Mohan
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

3.  Liver Transplantation without Perioperative Transfusions Single-Center Experience Showing Better Early Outcome and Shorter Hospital Stay.

Authors:  Nicolás Goldaracena; Patricio Méndez; Emilio Quiñonez; Gustavo Devetach; Lucio Koo; Carlos Jeanes; Margarita Anders; Federico Orozco; Pablo D Comignani; Ricardo C Mastai; Lucas McCormack
Journal:  J Transplant       Date:  2013-12-12

4.  Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis.

Authors:  Yili Zhang; Yangmin Zhang; Mei Zhang; Zhenhua Ma; Shengli Wu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

Review 5.  Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.

Authors:  Thomas Resch; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Julia Dumfarth; Christoph Krapf; Claudia Boesmueller; Dietmar Oefner; Michael Grimm; Sefan Schneeberger
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.